Franklyn G. Prendergast - 16 Jun 2021 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
Purananand D. Sarma, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
4
Filing time
21 Jun 2021, 20:07:12 UTC
Next filing
17 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock Option (Right to Buy) Award $0 +7,500 $0.000000 7,500 16 Jun 2021 Common Stock 7,500 $16.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest one-twelfth (1/12th) every quarter after the grant date.